A dialysis facility in FL. It ran an operating surplus of 6.5% in FY22 on $0.5M of operating revenue. It held 84 days of cash on hand (72nd percentile among dialysis facilities on liquidity). Only a single comparable reporting year is available, so trend context is limited.
Operating margin · FY22
+6.5%
vs dialysis facilities38th pctl of 7,741
Days cash on hand · FY22
84d
all sources
vs dialysis facilities72nd pctl
Total operating revenue · FY22
$0.5M
vs dialysis facilities5th pctl
Total margin · incl. nonoperating · FY22
+14.6%
vs dialysis facilities58th pctl
Where DIALYSIS 682741 sits among dialysis facilities
Operating margin · FY22 pool · n = 7,741 of 7,741 filed
Each point is one dialysis facility in the national distribution for this provider type, placed by operating margin. Facilities are not matched on size, case mix, or market — that is the matched-peer comparison in the paid benchmark. The dialysis facility median is +11.9%. Descriptive context only, not a ranking.
One dialysis facilityDIALYSIS 682741dialysis facility median
The money
$ thousands · HCRIS cost-report basis · as filed, QA-gated
Ratios tell you how this dialysis facility is doing. Statements tell you what kind of organization it is, and where the money comes from. Every figure below traces to a public cost-report filing, shown as filed. A ratio renders only when every input is reported in the filing; a year missing its core lines is not shown; a year whose balance sheet does not reconcile is labeled. Not audited by Astrelis.
Operating margin
+6.5% (FY22)
Operating income ÷ total operating revenue
HCRIS WS G-3
Total margin
+14.6% (FY22)
Net income ÷ total revenue incl. nonoperating
HCRIS WS G-3
Days cash on hand
84d (FY22)
Cash & investments ÷ daily operating expense
HCRIS WS G / G-3
Current ratio
Not shown, outside plausibility bounds
Total current assets ÷ current liabilities
HCRIS WS G
Equity financing ratio
98% (FY22)
Total net assets ÷ total assets
HCRIS WS G
Days in net patient A/R
Not reported in this filing
Net patient receivables ÷ (net patient revenue ÷ 365), same fiscal year
HCRIS WS G / G-3
$ in thousands
Line item
FY22
Patient revenue
530
Total operating revenue
530
Total operating expenses
495
Operating income
34
Operating margin %
+6.4%
Other non-operating, net
50
Net income
84
Net income %
+14.5%
1 of 3 years available for this statement.
HCRIS CMS-265 cost report · $ thousands · FY22–FY22 · operating revenue reflects net patient service revenue
How it operates
quality & operational context · CMS public reporting
The metrics this dialysis facility type is judged on: care quality, patient experience, and scale. Each is labeled by evidence class and public source; descriptive context only, never a ranking or adequacy claim.
Total treatments
66
Verified fact2022
HCRIS CMS-265
Cost per treatment ($)
7,505
Verified fact2022
HCRIS CMS-265
Net revenue per treatment ($)
8,025
Verified fact2022
HCRIS CMS-265
Trajectory
Cost-report basis · single reporting year
Operating margin
Days cash on hand
The county this dialysis facility serves
Location, FL
County demographic and economic context (Census, CDC, HRSA sources) extends to this dialysis facility cohort in an upcoming release.
The Board Briefing$1,000
The free profile shows the record. The Board Briefing tells you what changed, what matters, and what your board should ask. 35+ pages, built entirely from public sources, no client data required. Delivered within 2 business days. If we cannot deliver the published scope for your facility, you pay nothing.
